COVID-19 pandemic
The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting a WHO review amidst reports of cases of blood clots in vaccinated people from several European countries.
Sources: Nikkei Asia
Changes
- The Indonesian Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting WHO review amid reports of blood clot cases among the vaccinated people in several European countries.
- The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting WHO review amid reports of blood clot cases among the vaccinated people in several European countries.
- Portuguese Directorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of "rare, but serious" side-effects among vaccinated people.
- The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting WHO review amidst reports of blood clot cases amongst vaccinated people in several European countries.
- Germany, Italy, France, and Spain suspend the use of the Oxford–AstraZeneca vaccine following reports of severe side effects.
- The Portuguese Directorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of "rare, but serious" side-effects among vaccinated people.
- Latvian health authorities temporarily suspends temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of blood clot issues among vaccinated people.
- Latvian health authorities temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of blood clot issues among vaccinated people.
- The Directorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of "rare, but severe" suspected side-effects among vaccinated people in other countries.
- Latvian health authorities temporarily suspend the use of the Oxford–AstraZeneca vaccine as a precaution following reports of blood clot issues among vaccinated people.
- The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting a WHO review amidst reports of cases of blood clots in vaccinated people from several European countries.